ARTICLE | Clinical News
Betafectin: Began randomized, double-blind Phase I study in 25 normal individuals to evaluate the effect of increasing doses with or without growth factor suppo
October 23, 1995 7:00 AM UTC
Alpha-Beta Technology Inc. (ABTI), Worcester, Mass. Product: Betafectin, PGG-glucan carbohydrate Indication: Peripheral blood precursor cell mobilization in high dose chemotherapy Status: Began rando...